AstraZeneca-DRL patent case: Fate of Rs 2.35 bn drug to be decided today

AstraZeneca has dragged Dr Reddy's Laboratories to the court to protect its blood clot inhibitor drug Brilinta from generic competition

from Latest News https://ift.tt/2Kdnw7F